Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Scleroderma
100%
Bacterial Overgrowth
100%
Intestinal Bacterial
100%
Octreotide
100%
Intestinal Motility
100%
Hydrogen Excretion
27%
Motilin
27%
Breath Hydrogen
27%
Motility
18%
Abdominal Symptoms
18%
Nausea
9%
Abdominal Pain
9%
Small Intestine
9%
Bloating
9%
Motor Activity
9%
Short-term Administration
9%
Emesis
9%
Intestinal Dysmotility
9%
Somatostatin Analogs
9%
Motor Effects
9%
Pseudo-obstruction
9%
Intestinal Activity
9%
Stimulatory Agents
9%
Medicine and Dentistry
Intestine Motility
100%
Bacterial Overgrowth
100%
Scleroderma
100%
Octreotide
100%
Breathing
27%
Motilin
27%
Nausea
9%
Abdominal Pain
9%
Small Intestine
9%
Bloating
9%
Motor Activity
9%
Somatostatin Derivative
9%
Intestinal Dysmotility
9%
Pseudoobstruction
9%
Immunology and Microbiology
Scleroderma
100%
Intestine Motility
100%
Bacterial Overgrowth
100%
Normal Human
66%
Breathing
33%
Motilin
33%
Blood Plasma
22%
Small Intestine
11%
Somatostatin Analog
11%
Pharmacology, Toxicology and Pharmaceutical Science
Scleroderma
100%
Octreotide
100%
Normal Human
54%
Motilin
27%
Nausea
9%
Abdominal Pain
9%
Bloating
9%
Somatostatin Derivative
9%
Intestinal Dysmotility
9%
Pseudoobstruction
9%